Results 51 to 60 of about 3,268,533 (214)

Directed Search of Biologically Active Compounds Among Hydrogenated Isoindolylalkyl(alkylaryl-,aryl-)carboxylic acids with Quinazoline Fragment that Modify the Carbohydrate Metabolism: Design, Synthesis and Modification

Acta Chimica Slovenica, 2019
An effective synthesis of (3H-quinazoline-4-ylidene)hydrazides of N-carboxyalkyl-(arylalkyl-,aryl-)isoindoline-1,3-diones, using activated N-protected aminoacids and 4-hydrazinoquinazoline was proposed in the framework methodology of directed search of ...
Yulya Victorivna Martynenko, Oleksii Mykolayovich Antypenko, Olexandr Anatolievich Brazhko, Irina Borisivna Labenska, Sergii Ivanovich Kovalenko   +4 more
doaj   +1 more source

Synthesis and Characterization of Cinnamon Loaded BSA Microparticles with Antidiabetic Properties

Biology, Medicine & Natural Product Chemistry, 2023
Conventional medicine that is being used to treat diabetes exert adverse side effects and therefore scientists have focused on natural hypoglycemic agents.
Binuki Wanniarachchi, H.M.W.K. Sathsarani, Bimali M. Jayawardena, H.G.N. Dewangani   +3 more
doaj   +1 more source

A Pilot Study: The Beneficial Effects of Combined Statin-exercise Therapy on Cognitive Function in Patients with Coronary Artery Disease and Mild Cognitive Decline. [PDF]

, 2017
Objective Hypercholesterolemia, a risk factor in cognitive impairment, can be treated with statins. However, cognitive decline associated with "statins" (HMG-CoA reductase inhibitors) is a clinical concern.
Hamada, Mari, Horio, Eiji, Iwasaki, Yuri, Nakamura, Shinichi, Ogawa, Hisao, Oka, Hideki, Rokutanda, Taku, Spin, Joshua M, Sugiyama, Seigo, Toyama, Kensuke, Tsao, Philip S   +10 more
core   +1 more source

Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient‐ and physician‐related factors): A prospective observational DIPP‐FACTOR study in Korea

Journal of Diabetes Investigation, 2017
To assess the time to initiation of insulin therapy, and concurrently investigate both patient‐ and physician‐related factors associated with delaying insulin therapy in Korean patients with type 2 diabetes uncontrolled by oral hypoglycemic agents (OHAs).
S. Kim, Nam Hoon Kim, B. Ku, H. Shon, D. Kim, T. Park, Yong-Seong Kim, I. Kim, D. Choi   +8 more
semanticscholar   +1 more source

Treatment patterns in type 2 diabetes mellitus: A cross-sectional study

Indian Journal of Health Sciences and Biomedical Research KLEU, 2017
Introduction: Diabetes is one of the most common noncommunicable diseases in the world. There is an epidemic of diabetes in developing and nondeveloping countries.
Dhongadi Prashant, Sanjay Kambar
doaj   +1 more source

Drug-drug Interactions between Hypoglycemic and Non-hypoglycemic Medication in Diabetic Patients with Comorbidities in a Tertiary Care Center: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2021
Introduction: Drug-drug interaction is one of the causes of adverse drug reactions. Generally, drug-drug interaction is common in multidrug therapy.
Lujaw Ratna Tuladhar, Shirish Lal Shrestha, Sneha Bimali, Srijana Bhusal, Pingala Khadka   +4 more
doaj   +1 more source

Safety test of a supplement, 5-aminolevulinic acid phosphate with sodium ferrous citrate, in diabetic patients treated with oral hypoglycemic agents

, 2014
Objective: This study aimed to examine the safety of 5-aminolevulinic acid phosphate (5-ALA) with sodium ferrous citrate (SFC) in diabetic patients treated with one or more oral hypoglycemic agents (OHAs).
Naohide Yamashita, Atai Watanabe, Hikaru Kondo, Satofumi Kawata, Tohru Tanaka, Motowo Nakajima   +5 more
openalex   +3 more sources

Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database

Journal of Diabetes Investigation, 2016
In treatment algorithms of type 2 diabetes mellitus in Western countries, biguanides are recommended as first‐line agents. In Japan, various oral hypoglycemic agents (OHAs) are available, but prescription patterns are unclear.
M. Tanabe, R. Motonaga, Yuichi Terawaki, T. Nomiyama, T. Yanase   +4 more
semanticscholar   +1 more source

Oral Hypoglycemic Agents [PDF]

, 1977
In conclusion, comment is made on the findings of the University Group Diabetes Program (UGDP). The purpose of the UGDP was to determine whether or not control of blood glucose levels would help to prevent or delay vascular disease in non-insulin ...
Rifkin, Harold
core   +1 more source

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials. [PDF]

PLoS ONE, 2014
OBJECTIVE AND DESIGN: Gliclazide has been associated with a low risk of hypoglycemic episodes and beneficial long-term cardiovascular safety in observational cohorts.
Gijs W D Landman, Geertruide H de Bock, Kornelis J J van Hateren, Peter R van Dijk, Klaas H Groenier, Rijk O B Gans, Sebastiaan T Houweling, Henk J G Bilo, Nanne Kleefstra   +8 more
doaj   +1 more source